Abstract
Background: Oral squamous cell carcinoma (OSCC) and oropharyngeal squamous cell carcinoma (OPSCC) are very common in head and neck malignancy. Intratumour heterogeneity (ITH) may hamper their responses to treatment. Hence, novel tumour sampling methods that reflect ITH are required. In this study, we investigated the clinical significance of multi-site tumour sampling (MSTS) to detect ITH in OSCC and OPSCC.Methods: One hundred eighty-two paired specimens were sampled by routine sampling (RS) or MSTS, respectively. Histologically, tumour grade, peri-tumoural vascular and lymphatic growth, perineural permeation, tumour necrosis, and muscle invasion were assessed. Immunohistochemically, the positive and average detection rates of P53(mutant), ki67 and CyclinD1 were detected. The exon 9 and exon 20 mutations of PIK3CA gene and the methylation status of the CDKN2A promoter were analysed.Results: Microscopically, the detection rate of perineural permeation, the detection density of peri-tumoural vascular and lymphatic growth, necrosis and muscle invasion in MSTS were significantly more frequent than those in RP (P < 0.05, P < 0.05, P < 0.01, P < 0.01). MSTS resulted in a higher detection rate of P53 (mutant), ki67, and CyclinD1 expression than did RS, but the difference was not significant. MSTS's detection rates in PIK3CA gene mutation and gene methylation sequencing in CDKN2A gene promoter region were both higher than RP (P < 0.05, P < 0.01). To be emphasised, the hotspot mutation H1047Rwas detected in one MSTS specimen (case 24M5) but in no RS specimens.Conclusions: This study verified that MSTS's advantage in the reflection of morphological and molecular characteristics of OSCC and OPSCC. MSTS was more representative than RP. Therefore, MSTS can compensate the RP limitations in ITH detection especially in large tumours.
Highlights
Squamous cell carcinoma (SCC) is a common histological type in oral cavity and oropharynx [1]
One hundred eighty-two Oral squamous cell carcinoma (OSCC) and oropharyngeal squamous cell carcinoma (OPSCC) specimens with a maximum tumour diameter of ≥3 cm were collected from 26 patients (20 men and 6 women)
The test cases were diagnosed as oral squamous cell carcinoma (ICD code: 8070), HPV-negative oropharyngeal squamous cell carcinomas (ICD code: 8086), and HPV-positive oropharyngeal squamous cell carcinomas (ICD code: 8085), respectively
Summary
Squamous cell carcinoma (SCC) is a common histological type in oral cavity and oropharynx [1]. Targeted therapies have exerted potent and long-lasting anticancer effects, intratumour heterogeneity (ITH) could lead to treatment failure and therapeutic resistance [4–6]. It is common that well-differentiated, poorly differentiated, and moderately differentiated areas can co-exist within an carcinoma. These intra-tumoural differences in differentiation usually lead to varying patterns in lesions, which may cause differential expression of therapeutic targets and influence the treatment response [4]. Oral squamous cell carcinoma (OSCC) and oropharyngeal squamous cell carcinoma (OPSCC) are very common in head and neck malignancy. Intratumour heterogeneity (ITH) may hamper their responses to treatment. We investigated the clinical significance of multi-site tumour sampling (MSTS) to detect ITH in OSCC and OPSCC
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.